AbbVie’s Charles Holmes: On the Pandemic, Resuming Clinical Practice and Future Innovation
It’s already June . . . and depending on the country, people have been in quarantine or under shelter-in-place measures for months. In CAKE magazine’s continued Q&A from Quarantine coverage of the coronavirus, Media MICE CEO Matt Young spoke with Charles Holmes, associate VP and head of eyecare global for AbbVie, on how ophthalmology is both coping and emerging from the pandemic, as well as how the virus’s lasting impacts may alter future medical innovation. …
It’s already June . . . and depending on the country, people have been in quarantine or under shelter-in-place measures for months. In CAKE magazine’s continued Q&A from Quarantine coverage of the coronavirus, Media MICE CEO Matt Young spoke with Charles Holmes, associate VP and head of eyecare global for AbbVie, on how ophthalmology is both coping and emerging from the pandemic, as well as how the virus’s lasting impacts may alter future medical innovation. …
![[TFG] ESCRS Refractive Surgery Series ep. 1 thumbnail TFG Refractive Surgery Video Inte](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/02/TFG-ESCRS-Refractive-Surgery-Series-ep.-1-thumbnail-TFG-Refractive-Surgery-Video-Inte-579x326.png)
![[Internal] Data Visualization Video Dr. Gus Gazzard thumbnail Science Saves Sight Prof. Gus Gazzard on SLT vs. Drops for Glaucoma and IOP Control](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/01/Internal-Data-Visualization-Video-Dr.-Gus-Gazzard-thumbnail-Science-Saves-Sight-Prof.-Gus-Gazzard-on-SLT-vs.-Drops-for-Glaucoma-and-IOP-Control-579x326.jpg)
